Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.37 +0.51 (+1.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Cash from Investing Activities (2015 - 2026)

Updated

Lakefront Biotherapeutics' Cash from Investing Activities came in at $72 million for the quarter ended Mar 31, 2026, down 19.2% from $89.14 million a year earlier and down 14.8% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Cash from Investing Activities (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Lakefront Biotherapeutics reported Cash from Investing Activities of $307.43 million, up 4.1% year-over-year; for the year ended Dec 31, 2025, it was $326.31 million, up 36.7% from the prior year.

  • Cash from Investing Activities carries a five-year compound annual growth rate of -17.7% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Cash from Investing Activities was $238.76 million in the year ended Dec 31, 2024 (+211.7%), $76.59 million in the year ended Dec 31, 2023, -$1.31 billion in the year ended Dec 31, 2022 and $640.5 million in the year ended Dec 31, 2021 (-25.9%).
  • The five-year range for quarterly Cash from Investing Activities is -$1.27 billion (the quarter ended Dec 31, 2022) to $219.41 million (the quarter ended Jun 30, 2021).
  • Year-over-year, Cash from Investing Activities increased in four of the last six quarters, with growth averaging 31.3%.
  • Business Quant data shows LKFT's Cash from Investing Activities at $84.54 million (quarter ended Dec 31, 2025), $66.33 million (quarter ended Sep 30, 2025) and $84.57 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Lakefront Biotherapeutics 1.94 Bn 1.94 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 72.00 Mn
Dec 31, 2025 84.54 Mn
Sep 30, 2025 66.33 Mn
Jun 30, 2025 84.57 Mn
Mar 31, 2025 89.14 Mn
Dec 31, 2024 73.05 Mn
Sep 30, 2024 62.11 Mn
Jun 30, 2024 71.09 Mn
Mar 31, 2024 32.23 Mn
Dec 31, 2023 82.21 Mn
Mar 31, 2023 -309.84 Mn
Dec 31, 2022 -1.27 Bn
Mar 31, 2022 -1.05 Bn
Jun 30, 2021 219.41 Mn
Mar 31, 2021 602.95 Mn
Jun 30, 2020 -238.84 Mn
Mar 31, 2020 1.03 Bn
Dec 31, 2019 -4.17 Bn
Sep 30, 2019 -15.82 Mn
Jun 30, 2019 -5.91 Mn
API Access

Lakefront Biotherapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LKFT&period=max&api_key=YOUR_API_KEY